Esma Saâda
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 23
-
- Sarcoma Diagnosis and Treatment 24
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 9
- Cancer Diagnosis and Treatment 6
- Vascular Tumors and Angiosarcomas 5
- Rheumatology top 10%
-
- Lymphoma Diagnosis and Treatment 7
-
- Head and Neck Surgical Oncology 7
-
- Cardiac tumors and thrombi 6
- Co-authors
- Nicolás IsambertAntoîne ItalianoNicolas PenelJean‐Yves BlaySophie Piperno‐NeumannChristine ChevreauElsa KalbacherEmmanuelle Bompas
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (12 papers)European Archives of Oto-Rhino-Laryngology (7 papers)
- Partner nations
- FranceSpainUnited States
In The Last Decade
Esma Saâda
68 papers receiving 868 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Otorhinolaryngology 170
- Pulmonary and Respiratory Medicine 506
- Oncology 392
- Rheumatology 110
- Pathology and Forensic Medicine 110
Countries citing papers authored by Esma Saâda
This map shows the geographic impact of Esma Saâda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esma Saâda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esma Saâda more than expected).
Fields of papers citing papers by Esma Saâda
This network shows the impact of papers produced by Esma Saâda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esma Saâda. The network helps show where Esma Saâda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Esma Saâda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 12 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 26 | |
| 7 | 2020 | 24 | |
| 8 | 2020 | 58 | |
| 9 | 2018 | 9 | |
| 10 | Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 studybreakdown → | 2018 | 229 |
| 11 | 2016 | 13 | |
| 12 | 2016 | 14 | |
| 13 | 2015 | 20 | |
| 14 | 2014 | 7 | |
| 15 | 2013 | 20 | |
| 16 | 2012 | 9 | |
| 17 | 2011 | 12 | |
| 18 | 2011 | 2 | |
| 19 | 2009 | 24 | |
| 20 | 2009 | 2 |
About Esma Saâda
Esma Saâda is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Oncology, Gastroenterology and Pathology and Forensic Medicine, having authored 70 papers that have together received 874 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (24 papers), Head and Neck Cancer Studies (23 papers), Cancer Immunotherapy and Biomarkers (9 papers), Head and Neck Surgical Oncology (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Cardiac tumors and thrombi (6 papers), Cancer Diagnosis and Treatment (6 papers) and Vascular Tumors and Angiosarcomas (5 papers). The work is most often cited by research in Otorhinolaryngology (170 citations), Pulmonary and Respiratory Medicine (506 citations), Oncology (392 citations), Rheumatology (110 citations) and Pathology and Forensic Medicine (110 citations). Esma Saâda has collaborated with scholars based in France, Spain and United States. Frequent co-authors include Nicolás Isambert, Antoîne Italiano, Nicolas Penel, Jean‐Yves Blay, Sophie Piperno‐Neumann, Christine Chevreau, Elsa Kalbacher, Emmanuelle Bompas, Olivier Collard and Olivier Mir. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Archives of Oto-Rhino-Laryngology, European Journal of Cancer and Genes Chromosomes and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.